NCT03977662View on ClinicalTrials.gov

Pancreatic Islets and Parathyroid Gland Co-transplantation for Treatment of Type 1 Diabetes

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Type 1 Diabetes
Interventions
COMBINATION_PRODUCT

Co-transplantation of PTG with pancreatic islets

Co-transplantation of allogeneic parathyroid glands (PTG) with adult pancreatic islets (both PTG and pancreatic islets obtained from same deceased donor) in people with Type 1 diabetes in the intramuscular (IM) site with stable function of liver or kidney allografts on chronic immunosuppression

Trial Locations (1)

94143

University of California, San Francisco

All Listed Sponsors
collaborator

California Institute for Regenerative Medicine (CIRM)

OTHER

lead

Peter Stock

OTHER